Table 2 Incidence and severity of SRAEs
Group S (n = 60) | Group ES (n = 60) | P value | |
|---|---|---|---|
Total incidence | 51 (85.0%) | 34 (56.7%) | 0.001 |
Oxygen desaturation (75–90%) for 30 ~ 60 s | 38 (63.3%) | 14 (23.3%) | < 0.001 |
Oxygen desaturation (75–90%), severe (< 75% at any time) or prolonged (< 90% for> 60s) | 28 (46.7%) | 7 (11.7%) | < 0.001 |
Apnoea, not prolonged (30 ~ 60 s) | 44 (73.3%) | 17 (28.3%) | < 0.001 |
Apnoea, prolonged (> 60 s) | 32 (53.3%) | 8 (13.3%) | < 0.001 |
Airway obstruction/airway repositioning | 50 (83.3%) | 30 (50.0%) | < 0.001 |
Artificial assisted ventilation | 36 (60.0%) | 10 (16.7%) | < 0.001 |
Oral/nasal airway | 22 (36.7%) | 8 (13.3%) | 0.003 |
Hypotension/ephedrine as vasopressor | 17 (28.3%) | 8 (13.3%) | 0.043 |
Severity of SRAEs | < 0.001 | ||
No SRAEs | 5 | 15 | |
Minimal | 0 | 6 | |
Minor | 18 | 26 | |
Moderate | 12 | 8 | |
Sentinel | 25 | 5 |